Axonal degeneration is blocked by nicotinamide mononucleotide adenylyltransferase (Nmnat) protein transduction into transected axons

57Citations
Citations of this article
64Readers
Mendeley users who have this article in their library.

Abstract

Axonal degeneration is an early and important component of many neurological disorders. Overexpression of nicotinamide mononucleotide adenylyltransferase (Nmnat), a component of the slow Wallerian degeneration (Wlds) protein, protects axons from a variety of insults. We found that transduction of Nmnat protein into severed axons via virus-like particles prevented axonal degeneration. The post-injury efficacy of Nmnat indicates that its protective effects occur locally within the axon and provides an opportunity to develop novel agents to treat axonal damage. © 2010 by The American Society for Biochemistry and Molecular Biology, Inc.

Cite

CITATION STYLE

APA

Sasaki, Y., & Milbrandt, J. (2010). Axonal degeneration is blocked by nicotinamide mononucleotide adenylyltransferase (Nmnat) protein transduction into transected axons. Journal of Biological Chemistry, 285(53), 41211–41215. https://doi.org/10.1074/jbc.C110.193904

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free